177328-30-2

Basic information

• Product Name: 2-BROMO-4-PHENYL-5-THIAZOLECARBOXYLIC ACID ETHYL ESTER
• Synonyms: 2-BROMO-4-PHENYL-5-THIAZOLECARBOXYLIC ACID ETHYL ESTER;Ethyl 2-bromo-4-phenylthiazole-5-carboxylate;ethyl 2-bromo-4-phenyl-1,3-thiazole-5-carboxylate
• CAS NO: 177328-30-2
• Molecular Formula: C₁₂H₁₀BrNO₂S
• Molecular Weight: 312.18
• Mol File: 177328-30-2.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-BROMO-4-PHENYL-5-THIAZOLECARBOXYLIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BROMO-4-PHENYL-5-THIAZOLECARBOXYLIC ACID ETHYL ESTER(177328-30-2)
• EPA Substance Registry System: 2-BROMO-4-PHENYL-5-THIAZOLECARBOXYLIC ACID ETHYL ESTER(177328-30-2)

Safety Data

• Hazardous Substances Data: 177328-30-2(Hazardous Substances Data)

Upstream product

• 64399-23-1 ethyl 4-phenyl-2-aminothiazole-5-carboxylate 
• 55919-47-6 ethyl 2-bromo-3-oxo-3-phenylpropionate 

Downstream Products

• 87944-07-8 ethyl 2-[methyl(phenylmethyl)amino]-4-phenylthiazole-5-carboxylate 
• 906099-54-5 ethyl 2-{[2-(methylamino)-2-oxoethyl]thio}-4-phenyl-1,3-thiazole-5-carboxylate 
• 906099-52-3 ethyl 2-[(2-hydroxyethyl)thio]-4-phenyl-1,3-thiazole-5-carboxylate 
• 906099-58-9 ethyl 4-phenyl-2-(pyridin-3-yloxy)-1,3-thiazole-5-carboxylate 
• 906099-50-1 2-bromo-4-phenylthiazole-5-carboxylic acid 
• 906099-60-3 2-ethoxy-4-phenyl-1,3-thiazole-5-carboxylic acid 
• 1610354-67-0 2-(2-methylpyrimidin-5-yl)-4-phenylthiazole-5-carboxylic acid 
• 1610354-68-1 tert-butyl (2-(2-methylpyrimidin-5-yl)-4-phenylthiazol-5-yl)carbamate 
• 1610354-69-2 2-(2-methylpyrimidin-5-yl)-4-phenylthiazol-5-amine 
• 1610354-48-7 1-((3S,4R)-4-(3,4-difluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(2-(1-methyl-1H-pyrazol-4-yl)-4-phenylthiazol-5-yl )urea 

Relevant articles and documents

PYRROLIDINYL UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS

Compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts, or solvates or prodrugs thereof, where R1, R2, Ra, Rb, Rc, Rd, X, Ring B, and Ring C are as defined herein, and wherein Ring B moiety and the NH-C(=X)-NH moiety are in the trans configuration, are inhibitors of TrkA kinase and are useful in the treatment of diseases which can be treated with a TrkA kinase inhibitor such as pain, cancer, inflammation/inflammatory diseases, neurodegenerative diseases, certain infectious diseases, Sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis and pelvic pain syndrome.

PYRROLE CARBOXYLIC ACID DERIVATIVES AS ANTIBACTERIAL AGENTS

The present invention provides DNA Gyrase and/or Topo IV inhibitors of formula I, which can be used as antibacterial agents. Compounds disclosed herein can be used for treating or preventing conditions caused by or contributed by gram positive, gram negative and anaerobic bacteria, more particularly against, for example, Staphylococci, Streptococci, Enterococci, Haemophilus, Pseudomonus spp., Acenetobacter spp., Muraxalla spp., Chlamydia spp., Mycoplasma spp., Legionella spp., Mycobacterium spp., Helicobacter, Clostridium spp., Bacteroides spp., Cotyne bacterium, Bacillus spp., Enterobactericeae (E.coli, Klebsiella spp., Proteus spp.,etc.) or any combination thereof Also provided, are processes for preparing compounds disclosed herein, pharmaceutical compositions containing compounds disclosed herein, and methods of treating bacterial infections

Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists

This invention relates to novel benzofuran and dihydrobenzofuran compounds, pharmaceutical compositions containing such compounds, and methods of treating beta-3 adrenoreceptor-mediated conditions with such compositions.